<qa>  What is the purpose of the CANTOS sub-study 2?Sub-study 2 CACZ885M2301S2: The purpose of this CANTOS sub-study is to determine whether, in patients with type 2 diabetes participating in the CANTOS main study, canakinumab compared to placebo, on top of standard of care increases insulin secretion and insulin sensitivity. 